[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100376433":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":42,"centralContacts":46,"locations":52,"responsibleParty":71,"collaborators":73,"id":77,"slug":41,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":41,"eligibilityCriteria":82,"healthyVolunteers":78,"sex":83,"minAge":84,"maxAge":41,"enrollmentInfo":85,"targetDuration":41,"studyType":88,"phases":89,"briefSummary":91,"conditions":92,"keywords":41,"overallStatus":94,"whyStopped":41,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm I (isopropyl alcohol)","EXPERIMENTAL","Patients receive isopropyl alcohol via nasal inhalation.",[13,14],"Drug: Isopropyl Alcohol","Other: Questionnaire Administration",{"label":16,"type":17,"description":18,"interventionNames":19},"Arm II (placebo)","PLACEBO_COMPARATOR","Patients receive placebo via nasal inhalation.",[20,14],"Other: Placebo",[22,30,37],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"DRUG","Isopropyl Alcohol","Given via nasal inhalation",[9],[28,29],"Isopropanol","Isopropanolol",{"type":6,"name":31,"description":25,"armGroupLabels":32,"otherNames":33},"Placebo",[16],[34,35,36],"placebo therapy","PLCB","sham therapy",{"type":6,"name":38,"description":39,"armGroupLabels":40,"otherNames":41},"Questionnaire Administration","Ancillary studies",[9,16],null,[43],{"name":44,"affiliation":5,"role":45},"Yvonne J Heung","PRINCIPAL_INVESTIGATOR",[47],{"name":48,"role":49,"phone":50,"phoneExt":41,"email":51},"Michael J Tang, MD","CONTACT","(832) 468-8895","MJTang@mdanderson.org",[53],{"facility":54,"status":41,"city":55,"state":56,"zip":57,"country":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"M D Anderson Cancer Center","Houston","Texas","77030","United States",{"type":60,"coordinates":61},"Point",[62,63],-95.36327,29.76328,{"lat":63,"lon":62},[66,69],{"name":67,"role":49,"phone":68,"phoneExt":41,"email":41},"Michael J. Tang, MD","832-468-8895",{"name":70,"role":45,"phone":41,"phoneExt":41,"email":41},"Michael J. Tang",{"type":72,"investigatorFullName":41,"investigatorTitle":41,"investigatorAffiliation":41,"oldNameTitle":41,"oldOrganization":41},"SPONSOR",[74],{"name":75,"class":76},"National Cancer Institute (NCI)","NIH","100376433",false,"NCT04181463","Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer","Inhalation Approaches to Nausea: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Rate current severity of acute\u002Fchronic nausea \\>= 4 on NRS (Numeric Rating Scale)\n* Diagnosis of cancer\n* Able to read\u002Fwrite in English\n* Referred to supportive care service as an inpatient or outpatient\n* Rate anxiety as =\\\u003C 4 on ESAS-FS (Edmonton Symptom Assessment Scale-Financial Distress and Spiritual Pain)\n* Participants must agree to inhale isopropyl alcohol\n\nExclusion Criteria:\n\n* Received anti-emetics in the last 30 minutes\n* Received medical procedures (e.g. blood draws) which required exposure of isopropyl alcohol in the last 30 minutes\n* Inability to inhale through nares (including recent upper respiratory infection)\n* Known allergy to isopropyl alcohol\n* Delirium (i.e., score \\>= 7 on the Memorial Delirium Assessment Scale \\[MDAS\\])\n* Have never been on anti-emetics during the course of the treatment here (anti-emetic naive)","ALL","18 Years",{"count":86,"type":87},112,"ESTIMATED","INTERVENTIONAL",[90],"PHASE2","The goal of this research study is to understand the effect of inhalation approaches in reducing nausea in cancer patients.",[93],"Malignant Neoplasm","NOT_YET_RECRUITING","2026-05-26",{"date":97,"type":98},"2026-05-27","ACTUAL",{"date":100,"type":87},"2026-11-05",{"date":102,"type":87},"2028-12-30",{"name":5,"class":6},1]